{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:15:31Z","timestamp":1785608131170,"version":"3.56.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the grants of National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82474070"],"award-info":[{"award-number":["No. 82474070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2023YFD1601600"],"award-info":[{"award-number":["2023YFD1601600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00204-024-03941-w","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T13:16:03Z","timestamp":1735305363000},"page":"541-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular mechanisms behind the inhibitory effects of ginsenoside Rg3 on hepatic fibrosis: a review"],"prefix":"10.1007","volume":"99","author":[{"given":"Zhao-feng","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2988-4298","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"4","key":"3941_CR1","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/med.21881","volume":"42","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady A, Aslkhodapasandhokmabad H, Zhou Y et al (2022) Epigenetic modification in alcohol-related liver diseases. Med Res Rev 42(4):1463\u20131491","journal-title":"Med Res Rev"},{"key":"3941_CR2","doi-asserted-by":"publisher","first-page":"112934","DOI":"10.1016\/j.intimp.2024.112934","volume":"141","author":"HA Al Saihati","year":"2024","unstructured":"Al Saihati HA, Badr OA, Dessouky AA et al (2024) Exploring the cytoprotective role of mesenchymal stem cell-derived exosomes in chronic liver fibrosis: Insights into the Nrf2\/Keap1\/p62 signaling pathway. Int Immunopharmacol 141:112934","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"3941_CR3","first-page":"1382","volume":"77","author":"K Ani","year":"2022","unstructured":"Ani K, Marina S, Norah T et al (2022) Health disparities in chronic liver disease. Hepatology (Baltimore, Md) 77(4):1382\u20131403","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"20","key":"3941_CR4","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.3390\/molecules24203655","volume":"24","author":"S Bian","year":"2019","unstructured":"Bian S, Zhao Y, Li F et al (2019) 20(S)-ginsenoside Rg3 promotes HeLa cell apoptosis by regulating autophagy. Molecules 24(20):3655","journal-title":"Molecules"},{"key":"3941_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cellsig.2019.01.001","volume":"55","author":"E Borkham-Kamphorst","year":"2019","unstructured":"Borkham-Kamphorst E, Van de Leur E, Haas U et al (2019) Liver parenchymal cells lacking Lipocalin 2 (LCN2) are prone to endoplasmic reticulum stress and unfolded protein response. Cell Signal 55:90\u201399","journal-title":"Cell Signal"},{"issue":"46","key":"3941_CR6","doi-asserted-by":"publisher","first-page":"42728","DOI":"10.1074\/jbc.M103074200","volume":"276","author":"NS Chandel","year":"2001","unstructured":"Chandel NS, Schumacker PT, Arch RH (2001) Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem 276(46):42728\u201342736","journal-title":"J Biol Chem"},{"issue":"1","key":"3941_CR7","doi-asserted-by":"publisher","first-page":"41144","DOI":"10.1038\/srep41144","volume":"7","author":"XJ Chen","year":"2017","unstructured":"Chen XJ, Liu WJ, Wen ML et al (2017) Ameliorative effects of compound K and ginsenoside Rh1 on nonalcoholic fatty liver disease in rats. Sci Rep 7(1):41144","journal-title":"Sci Rep"},{"key":"3941_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0300-483X(84)90154-9","volume":"31","author":"E Chieli","year":"1984","unstructured":"Chieli E, Malvaldi G (1984) Role of the microsomal fad-containing monooxygenase in the liver toxicity of thioacetamide s-oxide. Toxicology 31:41\u201352","journal-title":"Toxicology"},{"issue":"12","key":"3941_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1124\/dmd.105.005520","volume":"33","author":"J Chilakapati","year":"2005","unstructured":"Chilakapati J, Shankar K, Korrapati MC et al (2005) Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metab Dispos 33(12):1877\u20131885","journal-title":"Drug Metab Dispos"},{"key":"3941_CR10","first-page":"1","volume":"55","author":"LP Christensen","year":"2009","unstructured":"Christensen LP (2009) Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. AdvFood Nutr Res 55:1\u201399","journal-title":"AdvFood Nutr Res"},{"key":"3941_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/15548627.2017.1319040","volume":"13","author":"KW Chung","year":"2017","unstructured":"Chung KW (2017) The critical role played by endotoxin-induced liver autophagy in the maintenance of lipid metabolism during sepsis. Autophagy 13:1113\u20131129","journal-title":"Autophagy"},{"issue":"6","key":"3941_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/10937404.2023.2220147","volume":"26","author":"SM Cohen","year":"2023","unstructured":"Cohen SM, Bevan C, Gollapudi B et al (2023) Evaluation of the carcinogenicity of carbon tetrachloride[J]. J Toxicol Environ Health B Crit Rev 26(6):342\u2013370","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"4","key":"3941_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","volume":"8","author":"F Cui","year":"2023","unstructured":"Cui F, Blach S, Manzengo Mingiedi C et al (2023) Global reporting of progress toward elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol 8(4):332\u2013342","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3941_CR14","doi-asserted-by":"publisher","first-page":"115177","DOI":"10.1016\/j.biopha.2023.115177","volume":"165","author":"C Ding","year":"2023","unstructured":"Ding C, Peng X, Yang J et al (2023) Rg3-loaded P407\/CS\/HA hydrogel inhibits UVB-induced oxidative stress, inflammation and apoptosis in HaCaT cells. Biomed Pharmacother 165:115177","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"3941_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10930-023-10147-z","volume":"42","author":"Y Dong","year":"2023","unstructured":"Dong Y, Wang X, Xu L et al (2023) Development of a chimeric protein BiPPB-mIFN\u03b3-tT\u03b2RII for improving the anti-fibrotic activity in vivo by targeting fibrotic liver and dual inhibiting the TGF-\u03b21\/Smad signaling pathway. Protein J 42(6):753\u2013765","journal-title":"Protein J"},{"issue":"7736","key":"3941_CR16","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1038\/d41586-018-07759-2","volume":"564","author":"L Drew","year":"2018","unstructured":"Drew L (2018) Liver cirrhosis: scar wars. Nature 564(7736):S73","journal-title":"Nature"},{"issue":"7999","key":"3941_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-023-06991-9","volume":"626","author":"W Fan","year":"2024","unstructured":"Fan W, Adebowale K, V\u00e1ncza L et al (2024) Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver. Nature 626(7999):635\u2013642","journal-title":"Nature"},{"issue":"1","key":"3941_CR18","doi-asserted-by":"publisher","first-page":"e12715","DOI":"10.1016\/j.heliyon.2022.e12715","volume":"9","author":"J Fang","year":"2022","unstructured":"Fang J, Ji Q, Gao S et al (2022) PDGF-BB is involved in HIF-1\u03b1\/CXCR4\/CXCR7 axis promoting capillarization of hepatic sinusoidal endothelial cells. Heliyon 9(1):e12715","journal-title":"Heliyon"},{"issue":"1","key":"3941_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","volume":"21","author":"G Feng","year":"2024","unstructured":"Feng G, Valenti L, Wong VW et al (2024) Recompensation in cirrhosis: unraveling the evolving natural history of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 21(1):46\u201356","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"3941_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","volume":"74","author":"J Galaski","year":"2021","unstructured":"Galaski J, Weiler-Normann C, Schakat M et al (2021) Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing. J Hepatol 74(2):312\u2013320","journal-title":"J Hepatol"},{"issue":"3","key":"3941_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jpp\/rgaa069","volume":"73","author":"Y Gao","year":"2021","unstructured":"Gao Y, Yan J, Li J et al (2021) Ginsenoside Rg3 ameliorates acetaminophen-induced hepatotoxicity by suppressing inflammation and oxidative stress. J Pharm Pharmacol 73(3):322\u2013331","journal-title":"J Pharm Pharmacol"},{"key":"3941_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fphar.2020.00500","volume":"11","author":"J Geng","year":"2020","unstructured":"Geng J, Fu W, Yu X et al (2020) Ginsenoside Rg3 alleviates ox-LDL induced endothelial dysfunction and prevents atherosclerosis in ApoE-\/-mice by regulating PPAR\u03b3\/FAK signaling pathway. Front Pharmacol 11:500","journal-title":"Front Pharmacol"},{"issue":"11","key":"3941_CR23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","volume":"137","author":"Y Gepner","year":"2018","unstructured":"Gepner Y, Shelef I, Schwarzfuchs D et al (2018) Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial. Circulation 137(11):1143\u20131157","journal-title":"Circulation"},{"key":"3941_CR24","doi-asserted-by":"publisher","first-page":"109056","DOI":"10.1016\/j.cbi.2020.109056","volume":"322","author":"FP Guengerich","year":"2020","unstructured":"Guengerich FP (2020) Cytochrome P450 2E1 and its roles in disease. Chem Biol Interact 322:109056","journal-title":"Chem Biol Interact"},{"key":"3941_CR25","doi-asserted-by":"publisher","first-page":"957947","DOI":"10.1155\/2013\/957947","volume":"2013","author":"SI Gum","year":"2013","unstructured":"Gum SI, Cho MK (2013) The amelioration of N-acetyl-p-benzoquinone imine toxicity by ginsenoside Rg3: the role of Nrf2-mediated detoxification and Mrp1\/Mrp3 transports. Oxid Med Cell Longev 2013:957947","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"3941_CR26","first-page":"4","volume":"9","author":"YF Guo","year":"2016","unstructured":"Guo YF, Li X, Chi L (2016) Research progress of anti-liver fibrosis effect of traditional Chinese medicine monomer. Glob Chin Med 9(9):4","journal-title":"Glob Chin Med"},{"issue":"1","key":"3941_CR27","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.1038\/s41598-023-34353-y","volume":"13","author":"F Hamberger","year":"2023","unstructured":"Hamberger F, Mederacke YS, Mederacke I (2023) An inducible model for genetic manipulation and fate-tracing of PDGFR\u03b2-expressing fibrogenic cells in the liver. Sci Rep 13(1):7322","journal-title":"Sci Rep"},{"issue":"1","key":"3941_CR28","first-page":"58","volume":"115","author":"A Hancu","year":"2011","unstructured":"Hancu A, Mihai MC, Axelerad AD (2011) Wilson\u2019s disease: a challenging diagnosis. Rev Med Chir Soc Med Nat Iasi 115(1):58\u201363","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"3941_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.omto.2021.08.008","volume":"22","author":"S He","year":"2021","unstructured":"He S, Tian S, He X et al (2021) Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma. Mol Ther Oncolytics 22:604\u2013616","journal-title":"Mol Ther Oncolytics"},{"key":"3941_CR30","first-page":"8858006","volume":"2021","author":"H Heeok","year":"2021","unstructured":"Heeok H, Delgerzul B, Gu SH (2021) Anticancer activities of ginsenosides, the main active components of ginseng. Evid-Based Complement Altern Med 2021:8858006","journal-title":"Evid-Based Complement Altern Med"},{"issue":"3","key":"3941_CR31","first-page":"259","volume":"9","author":"S Helms","year":"2004","unstructured":"Helms S (2004) Cancer prevention and therapeutics: Panax ginseng, Alternative medicine review. J Clin Therapeut 9(3):259\u2013274","journal-title":"J Clin Therapeut"},{"key":"3941_CR32","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","volume":"142","author":"V Hernandez-Gea","year":"2012","unstructured":"Hernandez-Gea V (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142:938\u2013946","journal-title":"Gastroenterology"},{"issue":"1","key":"3941_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/1472-6882-14-415","volume":"14","author":"YL Hou","year":"2014","unstructured":"Hou YL, Tsai YH, Lin YH et al (2014) Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats. BMC Complement. Altern Med 14(1):415","journal-title":"BMC Complement. Altern Med"},{"key":"3941_CR34","doi-asserted-by":"publisher","first-page":"155289","DOI":"10.1016\/j.phymed.2023.155289","volume":"124","author":"Y Hu","year":"2024","unstructured":"Hu Y, Lang Z, Li X et al (2024) Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression[J]. Phytomedicine 124:155289","journal-title":"Phytomedicine"},{"issue":"8","key":"3941_CR35","first-page":"2","volume":"32","author":"YY Huang","year":"2016","unstructured":"Huang YY, Xia T, Zhao CG et al (2016) Research progress on antitumor effects of ginsenoside Rh2 and Rg3[J]. J Pract Chin Med 32(8):2","journal-title":"J Pract Chin Med"},{"issue":"2","key":"3941_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/toxsci\/kfz193","volume":"172","author":"Z Huang","year":"2019","unstructured":"Huang Z, Chen M, Wei M et al (2019) Liver inflammatory injury initiated by DAMPs-TLR4-MyD88\/TRIF-NF\u03baB signaling pathway is involved in monocrotaline-induced HSOS. Toxicol Sci 172(2):385\u2013397","journal-title":"Toxicol Sci"},{"issue":"6","key":"3941_CR37","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jgr.2021.03.002","volume":"45","author":"WC Huang","year":"2021","unstructured":"Huang WC, Huang TH, Yeh KW et al (2021) Ginsenoside Rg3 ameliorates allergic airway inflammation and oxidative stress in mice. J Ginseng Res 45(6):654\u2013664","journal-title":"J Ginseng Res"},{"issue":"7","key":"3941_CR38","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1053\/j.gastro.2018.02.023","volume":"154","author":"M Ibrahim","year":"2018","unstructured":"Ibrahim M, Mostafa I, Devi\u00e8re J (2018) New developments in managing variceal bleeding. Gastroenterology 154(7):1964\u20131969","journal-title":"Gastroenterology"},{"issue":"2","key":"3941_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/cells9020461","volume":"9","author":"SR Ignat","year":"2020","unstructured":"Ignat SR, Dinescu S, Hermenean A et al (2020) Cellular interplay as a consequence of inflammatory signals leading to liver fibrosis development. Cells 9(2):461","journal-title":"Cells"},{"issue":"12","key":"3941_CR40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrgastro.2014.187","volume":"11","author":"L Isobel","year":"2014","unstructured":"Isobel L (2014) Liver disease: alcohol causes epigenetic changes in hepatic stellate cells. Nat Rev Gastroenterol Hepatol 11(12):704","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10464","key":"3941_CR41","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA et al (2024) Steatotic liver disease. Lancet 404(10464):1761\u20131778","journal-title":"Lancet"},{"issue":"31","key":"3941_CR42","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.3748\/wjg.v17.i31.3605","volume":"17","author":"JW Jiang","year":"2011","unstructured":"Jiang JW, Chen XM, Chen XH et al (2011) Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol 17(31):3605\u20133613","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3941_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3350\/cmh.2016.0035","volume":"23","author":"W Jo","year":"2017","unstructured":"Jo W, Suh YS, Lee SI et al (2017) Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy. Clin Mol Hepatol 23(2):184\u2013187","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"3941_CR44","doi-asserted-by":"publisher","first-page":"G182","DOI":"10.1152\/ajpgi.00361.2018","volume":"317","author":"MB Joseph","year":"2019","unstructured":"Joseph MB, Felicitas R, Robert S et al (2019) Combination of CClsub4\/sub with alcoholic and metabolic injuries mimics human liver fibrosis. Am J Physiol Gastrointest Liver Physiol 317(2):G182\u2013G194","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"3941_CR45","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/10715760701581740","volume":"41","author":"KS Kang","year":"2007","unstructured":"Kang KS, Kim HY, Yamabe N et al (2007) Preventive effect of 20(S)-ginsenoside Rg3 against lipopolysaccharide-induced hepatic and renal injury in rats. Free Radic Res 41(10):1181\u20131188","journal-title":"Free Radic Res"},{"issue":"11","key":"3941_CR46","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1016\/j.biocel.2013.08.016","volume":"45","author":"LJ Kang","year":"2020","unstructured":"Kang LJ, Choi YJ, Lee SG (2020) Stimulation of TRAF6\/TAK1 degradation and inhibition of JNK\/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. Int J Biochem Cell Biol 45(11):2612\u20132621","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"3941_CR47","doi-asserted-by":"publisher","first-page":"e165369","DOI":"10.1172\/jci.insight.165369","volume":"8","author":"J Kang","year":"2023","unstructured":"Kang J, Postigo-Fernandez J, Kim K et al (2023) Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis. JCI Insight 8(3):e165369","journal-title":"JCI Insight"},{"issue":"1","key":"3941_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s40425-019-0749-z","volume":"7","author":"BP Keenan","year":"2019","unstructured":"Keenan BP, Fong L, Kelley RK (2019) Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. J Immunother Cancer 7(1):267","journal-title":"J Immunother Cancer"},{"issue":"5","key":"3941_CR49","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/cells10051097","volume":"10","author":"A Khanam","year":"2021","unstructured":"Khanam A, Saleeb PG, Kottilil S (2021) Pathophysiology and treatment options for hepatic fibrosis: can it be completely cured. Cells 10(5):1097","journal-title":"Cells"},{"issue":"1","key":"3941_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells9010024","volume":"9","author":"O Khomich","year":"2019","unstructured":"Khomich O, Ivanov AV, Bartosch B (2019) Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells 9(1):24","journal-title":"Cells"},{"issue":"10","key":"3941_CR51","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/gut.2008.170233","volume":"58","author":"N Kim","year":"2009","unstructured":"Kim N, Yoo W, Lee J et al (2009) Formation of vitamin A lipid droplets in pancreatic stellate cells requires albumin. Gut 58(10):1382\u20131390","journal-title":"Gut"},{"issue":"12","key":"3941_CR52","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.18632\/oncotarget.2034","volume":"5","author":"DG Kim","year":"2014","unstructured":"Kim DG, Jung KH, Lee DG et al (2014) 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget 5(12):4438\u20134451","journal-title":"Oncotarget"},{"issue":"5","key":"3941_CR53","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3892\/ijmm.2017.2922","volume":"39","author":"JY Kim","year":"2017","unstructured":"Kim JY, An HJ, Kim WH et al (2017a) Apamin suppresses biliary fibrosis and activation of hepatic stellate cells. Int J Mol Med 39(5):1188\u20131194","journal-title":"Int J Mol Med"},{"issue":"1","key":"3941_CR54","doi-asserted-by":"publisher","first-page":"17670","DOI":"10.1038\/s41598-017-17956-0","volume":"7","author":"MK Kim","year":"2017","unstructured":"Kim MK, Lee SK, Park JH et al (2017) Ginsenoside Rg3 decreases fibrotic and invasive nature of endometriosis by modulating miRNA-27b in vitro and in vivo studies. Sci Rep 7(1):17670","journal-title":"Sci Rep"},{"issue":"3","key":"3941_CR55","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/hep.29177","volume":"66","author":"SJ Kim","year":"2017","unstructured":"Kim SJ, Jang JY, Kim EJ et al (2017c) Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation. Hepatology 66(3):758\u2013771","journal-title":"Hepatology"},{"issue":"1","key":"3941_CR56","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13046-016-0448-2","volume":"35","author":"F Kong","year":"2016","unstructured":"Kong F, Hu W, Zhou K et al (2016a) Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-\u03baB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells. J Exp Clin Cancer Res 35(1):172","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3941_CR57","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11626-016-0005-5","volume":"52","author":"F Kong","year":"2016","unstructured":"Kong F, Wang H, Guo J et al (2016b) Hsp70 suppresses apoptosis of BRL cells by regulating the expression of Bcl-2, cytochrome C, and caspase 8\/3. In Vitro Cell Dev Biol Anim 52(5):568\u2013575","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"5","key":"3941_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F (2017) Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol 17(5):306\u2013321","journal-title":"Nat Rev Immunol"},{"key":"3941_CR59","doi-asserted-by":"publisher","first-page":"154950","DOI":"10.1016\/j.phymed.2023.154950","volume":"118","author":"Z Lang","year":"2023","unstructured":"Lang Z, Yu S, Hu Y et al (2023) Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11. Phytomedicine 118:154950","journal-title":"Phytomedicine"},{"issue":"10","key":"3941_CR60","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1248\/bpb.28.1992","volume":"28","author":"HU Lee","year":"2005","unstructured":"Lee HU, Bae EA, Han MJ et al (2005) Hepatoprotective effect of 20(S)-ginsenosides Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxide-induced liver injury. Biol Pharm Bull 28(10):1992\u20131994","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"3941_CR61","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.fct.2012.01.005","volume":"50","author":"CK Lee","year":"2012","unstructured":"Lee CK, Park KK, Chung AS et al (2012) Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1\/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species. Food Chem Toxicol 50(7):2565\u20132574","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"3941_CR62","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/biom10101426","volume":"10","author":"JH Lee","year":"2020","unstructured":"Lee JH, Oh JY et al (2020) Pharmaceutical efficacy of gypenoside LXXV on non-alcoholic steatohepatitis (NASH). Biomolecules 10(10):1426","journal-title":"Biomolecules"},{"issue":"1","key":"3941_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27\u201342","journal-title":"Cell"},{"key":"3941_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ymeth.2020.10.002","volume":"187","author":"S Li","year":"2021","unstructured":"Li S, Tollefsbol OT (2021) DNA methylation methods: global DNA methylation and methylomic analyses. Methods 187:28\u201343","journal-title":"Methods"},{"issue":"39","key":"3941_CR65","doi-asserted-by":"publisher","first-page":"14833","DOI":"10.1039\/C4DT02065K","volume":"43","author":"XX Li","year":"2014","unstructured":"Li XX, Zheng QC, Wang Y et al (2014) Theoretical insights into the reductive metabolism of CCl4 by cytochrome P450 enzymes and the CCl4-dependent suicidal inactivation of P450. Dalton Trans 43(39):14833\u201314840","journal-title":"Dalton Trans"},{"issue":"22","key":"3941_CR66","doi-asserted-by":"publisher","first-page":"e129013","DOI":"10.1172\/jci.insight.129013","volume":"4","author":"S Li","year":"2019","unstructured":"Li S, Yi Z, Deng M et al (2019) TSLP protects against liver I\/R injury via activation of the PI3K\/Akt pathway. JCI Insight 4(22):e129013","journal-title":"JCI Insight"},{"issue":"3","key":"3941_CR67","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11596-020-2211-3","volume":"40","author":"HG Li","year":"2020","unstructured":"Li HG, You PT, Xia Y et al (2020a) Yu Gan Long ameliorates hepatic fibrosis by inhibiting PI3K\/AKT, Ras\/ERK and JAK1\/STAT3 signaling pathways in CCl4-induced liver fibrosis rats. Curr Med Sci 40(3):539\u2013547","journal-title":"Curr Med Sci"},{"issue":"5","key":"3941_CR68","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1142\/S0192415X20500561","volume":"48","author":"W Li","year":"2020","unstructured":"Li W, Wang JQ, Zhou YD et al (2020b) Rare ginsenoside 20(R)-Rg3 inhibits d-galactose-induced liver and kidney injury by regulating oxidative stress-induced apoptosis. Am J Chin Med 48(5):1141\u20131157","journal-title":"Am J Chin Med"},{"issue":"04","key":"3941_CR69","first-page":"383","volume":"43","author":"W Li","year":"2021","unstructured":"Li W, Wang Y, Liu W (2021) Research progress on development and utilization of non-medicinal parts of ginseng and American ginseng. J Jilin Agric Univ 43(04):383\u2013392","journal-title":"J Jilin Agric Univ"},{"issue":"1","key":"3941_CR70","first-page":"82","volume":"16","author":"Y Li","year":"2024","unstructured":"Li Y, Li F, Ding M et al (2024) Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway. Chin Herb Med 16(1):82\u201393","journal-title":"Chin Herb Med"},{"key":"3941_CR71","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W et al (2022) CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40:365\u2013378","journal-title":"Cancer Cell"},{"key":"3941_CR72","doi-asserted-by":"publisher","first-page":"1206737","DOI":"10.1155\/2018\/1206737","volume":"2018","author":"P Liu","year":"2018","unstructured":"Liu P, Chen L, Zhang H (2018) Natural killer cells in liver disease and hepatocellular carcinoma and the NK cell-based immunotherapy. J Immunol Res 2018:1206737","journal-title":"J Immunol Res"},{"issue":"4","key":"3941_CR73","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2019.05.029","volume":"71","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lu T, Zhang C et al (2019) Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury[J]. J Hepatol 71(4):719\u2013730","journal-title":"J Hepatol"},{"issue":"3","key":"3941_CR74","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s11033-021-06187-2","volume":"48","author":"Z Liu","year":"2021","unstructured":"Liu Z, Liu T, Li W et al (2021) Insights into the antitumor mechanism of ginsenosides Rg3. Mol Biol Rep 48(3):2639\u20132652","journal-title":"Mol Biol Rep"},{"key":"3941_CR75","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1002\/jsfa.11763","volume":"102","author":"H Liu","year":"2022","unstructured":"Liu H, Hu X, Li L et al (2022) Micron and nano hybrid ufasomes from conjugated linoleic acid, their vesiculation and encapsulation of ginsenoside Rg3. J Sci Food Agric 102:4140\u20134150","journal-title":"J Sci Food Agric"},{"key":"3941_CR76","doi-asserted-by":"publisher","first-page":"173578","DOI":"10.1016\/j.ejphar.2020.173578","volume":"888","author":"X Ma","year":"2020","unstructured":"Ma X, Jiang Y, Wen J et al (2020) A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds. Eur J Pharmacol 888:173578","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3941_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/liv.15119","volume":"42","author":"A Majumdar","year":"2022","unstructured":"Majumdar A, Tsochatzis EA (2022) Binge drinking and fibrogenesis: More than just a hangover. Liver Int 42(1):6\u20138","journal-title":"Liver Int"},{"issue":"2","key":"3941_CR78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41419-019-1327-5","volume":"10","author":"I Mannaerts","year":"2019","unstructured":"Mannaerts I, Thoen LFR, Eysackers N et al (2019) Unfolded protein response is an early, non-critical event during hepatic stellate cell activation. Cell Death Dis 10(2):98","journal-title":"Cell Death Dis"},{"issue":"4","key":"3941_CR79","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1086\/367643","volume":"36","author":"C Martinez-Sierra","year":"2003","unstructured":"Martinez-Sierra C, Arizcorreta A, D\u00edaz F et al (2003) Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 36(4):491\u2013498","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3941_CR80","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/jcb.27681","volume":"120","author":"N Masoud","year":"2019","unstructured":"Masoud N, Bagher F, Keywan M (2019) Extracellular matrix (ECM) stiffness and degradation as cancer drivers[J]. J Cell Biochem 120(3):2782\u20132790","journal-title":"J Cell Biochem"},{"issue":"8015","key":"3941_CR81","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41586-024-07376-2","volume":"630","author":"KP Matchett","year":"2024","unstructured":"Matchett KP, Wilson-Kanamori JR, Portman JR et al (2024) Multimodal decoding of human liver regeneration. Nature 630(8015):158\u2013165","journal-title":"Nature"},{"issue":"6","key":"3941_CR82","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","volume":"137","author":"R Mathew","year":"2009","unstructured":"Mathew R, Karp CM, Beaudoin B et al (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137(6):1062\u20131075","journal-title":"Cell"},{"issue":"5","key":"3941_CR83","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/hep.29025","volume":"65","author":"KS McCommis","year":"2017","unstructured":"McCommis KS, Hodges WT, Brunt EM et al (2017) Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis. Hepatology 65(5):1543\u20131556","journal-title":"Hepatology"},{"issue":"19","key":"3941_CR84","doi-asserted-by":"publisher","first-page":"14482","DOI":"10.3390\/ijms241914482","volume":"24","author":"A Morishita","year":"2023","unstructured":"Morishita A, Oura K, Tadokoro T et al (2023) MicroRNAs and nonalcoholic steatohepatitis: a review. Int J Mol Sci 24(19):14482","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3941_CR85","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2016.02.035","volume":"150","author":"LE Nagy","year":"2016","unstructured":"Nagy LE, Ding WX, Cresci G et al (2016) Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes. Gastroenterology 150(8):1756\u20131768","journal-title":"Gastroenterology"},{"issue":"3","key":"3941_CR86","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11418-024-01798-y","volume":"78","author":"Y Nakajima","year":"2024","unstructured":"Nakajima Y, Tsuboi N, Katori K et al (2024) Oxomollugin, an oxidized substance in mollugin, inhibited LPS-induced NF-\u03baB activation via the suppressive effects on essential activation factors of TLR4 signaling. J Nat Med 78(3):568\u2013575","journal-title":"J Nat Med"},{"issue":"13","key":"3941_CR87","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.3390\/ijms22136777","volume":"22","author":"SY Neshat","year":"2021","unstructured":"Neshat SY, Quiroz VM, Wang Y et al (2021) Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions. Int J Mol Sci 22(13):6777","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3941_CR88","doi-asserted-by":"publisher","first-page":"e2016003","DOI":"10.4084\/mjhid.2016.003","volume":"8","author":"TT Nguyen","year":"2016","unstructured":"Nguyen TT, Niloofar R, Rubbo PA et al (2016) Cytokine response associated with hepatitis C virus clearance in HIV coinfected patients initiating peg interferon-\u03b1 based therapy. Mediterr J Hematol Infect Dis 8(1):e2016003","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"4","key":"3941_CR89","first-page":"3001","volume":"22","author":"H Niwa","year":"2020","unstructured":"Niwa H, Kanno Y, Shu E et al (2020) Decrease in matrix metalloproteinase-3 activity in systemic sclerosis fibroblasts causes \u03b12-antiplasmin and extracellular matrix deposition, and contributes to fibrosis development. Mol Med Rep 22(4):3001\u20133007","journal-title":"Mol Med Rep"},{"issue":"3","key":"3941_CR90","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jep.2012.03.038","volume":"141","author":"HM Park","year":"2012","unstructured":"Park HM, Kim SJ, Mun AR et al (2012) Korean red ginseng and its primary ginsenosides inhibit ethanol-induced oxidative injury by suppression of the MAPK pathway in TIB-73 cells. J Ethnopharmacol 141(3):1071\u20131076","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3941_CR91","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jhep.2015.09.017","volume":"64","author":"M Parola","year":"2016","unstructured":"Parola M (2016) Age-dependent changes in extracellular matrix turnover: an under evaluated issue in the approach to chronic liver diseases. J Hepatol 64(1):13\u201315","journal-title":"J Hepatol"},{"issue":"3","key":"3941_CR92","first-page":"CD011602","volume":"3","author":"CS Pavlov","year":"2016","unstructured":"Pavlov CS (2016) Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev 3(3):CD011602","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"3941_CR93","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/apt.14066","volume":"45","author":"DJ Pinato","year":"2017","unstructured":"Pinato DJ, Howell J, Ramaswami R et al (2017) Review article: delivering precision oncology in intermediate-stage liver cancer. Aliment Pharmacol Ther 45(12):1514\u20131523","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"3941_CR94","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/nu11030507","volume":"11","author":"GH Prins","year":"2019","unstructured":"Prins GH, Luangmonkong T, Oosterhuis D et al (2019) A pathophysiological model of non-alcoholic fatty liver disease using precision-cut liver slices. Nutrients 11(3):507","journal-title":"Nutrients"},{"issue":"4","key":"3941_CR95","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/j.gastro.2021.12.250","volume":"162","author":"T Qian","year":"2022","unstructured":"Qian T, Fujiwara N, Koneru B et al (2022) Molecular signature predictive of long-term liver fibrosis progression to inform antifibrotic drug development. Gastroenterology 162(4):1210\u20131225","journal-title":"Gastroenterology"},{"issue":"2","key":"3941_CR96","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/pharmaceutics15020391","volume":"15","author":"S Rahimi","year":"2023","unstructured":"Rahimi S, van Leeuwen D, Roshanzamir F et al (2023) Ginsenoside Rg3 reduces the toxicity of graphene oxide used for pH-responsive delivery of doxorubicin to liver and breast cancer cells. Pharmaceutics 15(2):391","journal-title":"Pharmaceutics"},{"issue":"12","key":"3941_CR97","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.3390\/ijms21124318","volume":"21","author":"L Rao","year":"2020","unstructured":"Rao L, Xu Y, Reineke LC et al (2020) Post-transcriptional regulation of alpha one antitrypsin by a proteasome inhibitor. Int J Mol Sci 21(12):4318","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3941_CR98","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/hep.30214","volume":"69","author":"RB Ray","year":"2019","unstructured":"Ray RB, Ray R (2019) Hepatitis C virus manipulates humans as its favorite host for a long-term relationship. Hepatology 69(2):889\u2013900","journal-title":"Hepatology"},{"issue":"2","key":"3941_CR99","doi-asserted-by":"publisher","first-page":"e1905233","DOI":"10.1002\/smll.201905233","volume":"16","author":"Z Ren","year":"2020","unstructured":"Ren Z, Chen X, Hong L et al (2020) Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small 16(2):e1905233","journal-title":"Small"},{"issue":"4","key":"3941_CR100","doi-asserted-by":"publisher","first-page":"e0153118","DOI":"10.1371\/journal.pone.0153118","volume":"11","author":"S Robert","year":"2016","unstructured":"Robert S, Gicquel T, Bodin A et al (2016) Characterization of the MMP\/TIMP imbalance and collagen production induced by IL-1\u03b2 or TNF-\u03b1 release from human hepatic stellate cells. PLoS ONE 11(4):e0153118","journal-title":"PLoS ONE"},{"key":"3941_CR101","first-page":"126262","volume":"251","author":"G Ruirui","year":"2023","unstructured":"Ruirui G, Wanqiao L, Zhipeng L et al (2023) Effects and potential mechanisms of IGF1\/IGF1R in the liver fibrosis: a review. Int J Biol Macromol 251:126262\u2013126263","journal-title":"Int J Biol Macromol"},{"key":"3941_CR102","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","volume":"68\u201369","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Ashfaq-Khan M, Yang AT et al (2018) Liver fibrosis: direct antifibrotic agents and targeted therapies. Matrix Biol 68\u201369:435\u2013451","journal-title":"Matrix Biol"},{"issue":"7","key":"3941_CR103","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Tabas I, Pajvani UB (2020) Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158(7):1913\u20131928","journal-title":"Gastroenterology"},{"issue":"3","key":"3941_CR104","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/hep.28353","volume":"63","author":"JR Senior","year":"2016","unstructured":"Senior JR (2016) Can rechallenge be done safely after mild or moderate drug-induced liver injury. Hepatology 63(3):691\u2013693","journal-title":"Hepatology"},{"issue":"6","key":"3941_CR105","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1248\/bpb.b18-00852","volume":"42","author":"K Shan","year":"2019","unstructured":"Shan K, Wang Y, Hua H et al (2019) Ginsenoside Rg3 combined with oxaliplatin inhibits the proliferation and promotes apoptosis of hepatocellular carcinoma cells via downregulating PCNA and cyclin D1. Biol Pharm Bull 42(6):900\u2013905","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"3941_CR106","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/ijmm.2022.5144","volume":"50","author":"Y Shan","year":"2022","unstructured":"Shan Y, Li J, Zhu A et al (2022) Ginsenoside Rg3 ameliorates acute pancreatitis by activating the NRF2\/HO-1-mediated ferroptosis pathway. Int J Mol Med 50(1):89","journal-title":"Int J Mol Med"},{"issue":"2","key":"3941_CR107","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.26362","volume":"58","author":"SD Sharma","year":"2013","unstructured":"Sharma SD (2013) Hepatitis C virus 1b viral factors (core, NS3, and NS5A) and increased risk of hepatocellular carcinoma. Hepatology 58(2):491\u2013493","journal-title":"Hepatology"},{"issue":"8","key":"3941_CR108","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/biom14081019","volume":"14","author":"W Shi","year":"2024","unstructured":"Shi W, Zhang Z, Wang X (2024) The prospect of hepatic decellularized extracellular matrix as a bioink for liver 3D Bioprinting. Biomolecules 14(8):1019","journal-title":"Biomolecules"},{"issue":"10","key":"3941_CR109","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/1873-3468.13752","volume":"594","author":"S Shoji","year":"2020","unstructured":"Shoji S, Hanada K, Takahashi M et al (2020) The NF-\u03baB regulator I\u03baB\u03b2 exhibits different molecular interactivity and phosphorylation status from I\u03baB\u03b1 in an IKK2-catalysed reaction. FEBS Lett 594(10):1532\u20131549","journal-title":"FEBS Lett"},{"issue":"5","key":"3941_CR110","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/BF02256534","volume":"9","author":"EC So","year":"2002","unstructured":"So EC, Wong KL, Huang TC et al (2002) Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity. J Biomed Sci 9(5):410\u2013414","journal-title":"J Biomed Sci"},{"issue":"6","key":"3941_CR111","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbadis.2013.02.005","volume":"1832","author":"A Sokolovi\u0107","year":"2013","unstructured":"Sokolovi\u0107 A, Rodriguez-Ortigosa CM, Bloemendaal LT et al (2013) Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-\/-) mice. Biochim Biophys Acta 1832(6):697\u2013704","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3941_CR112","doi-asserted-by":"publisher","first-page":"e13271","DOI":"10.1111\/sji.13271","volume":"98","author":"L Song","year":"2023","unstructured":"Song L, Xu R, Cai W et al (2023) IL-6 upregulates the expression of IL-6R through the JAK2\/STAT3 signalling pathway to promote progression of hepatocellular carcinoma. Scand J Immunol 98(1):e13271","journal-title":"Scand J Immunol"},{"issue":"009","key":"3941_CR113","first-page":"1912","volume":"048","author":"YY Sun","year":"2017","unstructured":"Sun YY, Zhao YJ, Zhao JC et al (2017) Research progress on the mechanism of ginsenoside in anti-liver fibrosis. Chin Herb Med 048(009):1912\u20131915","journal-title":"Chin Herb Med"},{"issue":"1","key":"3941_CR114","first-page":"965","volume":"17","author":"MY Sun","year":"2019","unstructured":"Sun MY, Song YN, Zhang M et al (2019) Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9. Oncol Lett 17(1):965\u2013973","journal-title":"Oncol Lett"},{"issue":"1","key":"3941_CR115","first-page":"109","volume":"33","author":"S Sun","year":"2020","unstructured":"Sun S, Guan Q, Shang E et al (2020) Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment. Pak J Pharmaceut Sci 33(1):109\u2013119","journal-title":"Pak J Pharmaceut Sci"},{"issue":"4","key":"3941_CR116","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/hep.30763","volume":"70","author":"N Sutherland","year":"2019","unstructured":"Sutherland N, Li Wai Suen CFD, Mills C et al (2019) Fibrosing cholestatic hepatitis-like syndrome in an immunocompetent patient with an acute flare of chronic hepatitis B. Hepatology 70(4):1480\u20131483","journal-title":"Hepatology"},{"issue":"3","key":"3941_CR117","first-page":"1487","volume":"41","author":"M Tang","year":"2018","unstructured":"Tang M, Bian W, Cheng L et al (2018) Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF-\u03b2\/Smad and ERK signaling pathways. Int J Mol Med 41(3):1487\u20131499","journal-title":"Int J Mol Med"},{"issue":"7","key":"3941_CR118","first-page":"5","volume":"28","author":"LL Tang","year":"2022","unstructured":"Tang LL, Li HY, Liu WS et al (2022) Research progress of ginsenoside Rg3 in anti-hepatocellular carcinoma. Int Med Health Rev 28(7):5","journal-title":"Int Med Health Rev"},{"issue":"3","key":"3941_CR119","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1021\/mp1004228","volume":"8","author":"EA Vasievich","year":"2011","unstructured":"Vasievich EA, Huang L (2011) The suppressive tumor microenvironment: a challenge in cancer immunotherapy. Mol Pharm 8(3):635\u2013641","journal-title":"Mol Pharm"},{"issue":"2","key":"3941_CR120","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/bios13020212","volume":"13","author":"J Wan","year":"2023","unstructured":"Wan J, Cheng W, Xing X et al (2023) A SERS-based dual-parameter monitoring nanoprobe of ROS and PI3K\/Akt during Ginsenoside Rg3-Induced Cell Apoptosis. Biosensors 13(2):212","journal-title":"Biosensors"},{"issue":"1","key":"3941_CR121","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbrc.2005.12.175","volume":"341","author":"YQ Wang","year":"2006","unstructured":"Wang YQ, Luk JM, Chu AC et al (2006) TNP-470 blockage of VEGF synthesis is dependent on MAPK\/COX-2 signaling pathway in PDGF-BB-activated hepatic stellate cells. Biochem Biophys Res Commun 341(1):239\u2013244","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3941_CR122","first-page":"711","volume":"68","author":"B Wang","year":"2021","unstructured":"Wang B, Xu Q, Zhou C et al (2021) Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma. Acta Biochim Pol 68(4):711\u2013715","journal-title":"Acta Biochim Pol"},{"key":"3941_CR123","doi-asserted-by":"publisher","first-page":"975784","DOI":"10.3389\/fphar.2022.975784","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Zeng L, Zhang Y et al (2022) Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent. Front Pharmacol 13:975784","journal-title":"Front Pharmacol"},{"issue":"2","key":"3941_CR124","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/apa.16572","volume":"112","author":"L Wang","year":"2023","unstructured":"Wang L, Liu S, Wang C et al (2023) Hepatocyte proliferation favors viral clearance in young children with chronic hepatitis B virus infection. Acta Paediatr 112(2):305\u2013310","journal-title":"Acta Paediatr"},{"issue":"2","key":"3941_CR125","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jgr.2023.11.004","volume":"48","author":"W Wang","year":"2024","unstructured":"Wang W, Li K, Xiao W (2024a) The pharmacological role of Ginsenoside Rg3 in liver diseases: a review on molecular mechanisms. J Ginseng Res 48(2):129\u2013139","journal-title":"J Ginseng Res"},{"issue":"3","key":"3941_CR126","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/HEP.0000000000000569","volume":"79","author":"F Wang","year":"2024","unstructured":"Wang F, Chen L, Kong D et al (2024b) Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1\u03b1 transcriptional complex. Hepatology 79(3):606\u2013623","journal-title":"Hepatology"},{"issue":"19","key":"3941_CR127","doi-asserted-by":"publisher","first-page":"11696","DOI":"10.3390\/ijms231911696","volume":"23","author":"M Wei","year":"2022","unstructured":"Wei M, Yan X, Xin X et al (2022) Hepatocyte-specific Smad4 deficiency alleviates liver fibrosis via the p38\/p65 pathway. Int J Mol Sci 23(19):11696","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3941_CR128","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41419-020-2597-7","volume":"11","author":"L Xiangxiang","year":"2020","unstructured":"Xiangxiang L, Xiaojie M, Zi W et al (2020) Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis 11(6):454","journal-title":"Cell Death Dis"},{"issue":"1","key":"3941_CR129","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1080\/21691401.2019.1575231","volume":"47","author":"L Xie","year":"2019","unstructured":"Xie L, Huang Y (2019) Antagonism of RIP1 using necrostatin-1 (Nec-1) ameliorated damage and inflammation of HBV X protein (HBx) in human normal hepatocytes. Artif Cells Nanomed Biotechnol 47(1):1194\u20131199","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"3941_CR130","first-page":"1286","volume":"39","author":"LM Xu","year":"2019","unstructured":"Xu LM, Liu P, Shen XZ et al (2019) Guidelines for the diagnosis and treatment of liver fibrosis with integrated traditional Chinese and Western medicine (2019Annual Edition). Chin J Integr Tradit Chin West Med 39(11):1286\u20131295","journal-title":"Chin J Integr Tradit Chin West Med"},{"issue":"1","key":"3941_CR131","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41598-023-50680-6","volume":"14","author":"S Yeonhwa","year":"2024","unstructured":"Yeonhwa S, Namjeong K, Jinyeong H et al (2024) Inhibition of DNMT3B expression in activated hepatic stellate cells overcomes chemoresistance in the tumor microenvironment of hepatocellular carcinoma. Sci Rep 14(1):115\u2013115","journal-title":"Sci Rep"},{"issue":"003","key":"3941_CR132","first-page":"303","volume":"35","author":"TX Yin","year":"2015","unstructured":"Yin TX, Wang YY (2015) Effects of ginsenoside Rg3 on proliferation, migration, adhesion and apoptosis of human hepatocellular carcinoma cells and its mechanism. Basic Med Clin Med 35(003):303\u2013307","journal-title":"Basic Med Clin Med"},{"issue":"2","key":"3941_CR133","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7150\/ijms.29930","volume":"16","author":"H Ying-Hsien","year":"2019","unstructured":"Ying-Hsien H, Hsing-Chun K, Ya-Ling Y et al (2019) MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. Int J Med Sci 16(2):212\u2013220","journal-title":"Int J Med Sci"},{"key":"3941_CR134","doi-asserted-by":"publisher","first-page":"624725","DOI":"10.3389\/fimmu.2021.624725","volume":"12","author":"X Yingying","year":"2021","unstructured":"Yingying X, Guojing R, Haiwei N et al (2021) Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression. Front Immunol 12:624725\u2013624725","journal-title":"Front Immunol"},{"issue":"1","key":"3941_CR135","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/hep.510300147","volume":"30","author":"KF Yoong","year":"1999","unstructured":"Yoong KF, Afford SC, Jones R et al (1999) Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology 30(1):100\u2013111","journal-title":"Hepatology"},{"key":"3941_CR136","doi-asserted-by":"publisher","first-page":"155289","DOI":"10.1016\/j.phymed.2023.155289","volume":"124","author":"H Yuhang","year":"2024","unstructured":"Yuhang H, Zhichao L, Xinmiao L et al (2024) Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression. Phytomedicine 124:155289","journal-title":"Phytomedicine"},{"key":"3941_CR137","doi-asserted-by":"publisher","first-page":"106099","DOI":"10.1016\/j.phrs.2022.106099","volume":"177","author":"SN Zarneshan","year":"2022","unstructured":"Zarneshan SN, Fakhri S, Khan H (2022) Targeting Akt\/CREB\/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: a mechanistic approach. Pharmacol Res 177:106099","journal-title":"Pharmacol Res"},{"issue":"39","key":"3941_CR138","first-page":"119","volume":"05","author":"B Zhou","year":"2016","unstructured":"Zhou B, Yan ZP, Liu R et al (2016) A prospective study of transcatheter arterial chemoembolization (TACE) combined with ginsenoside Rg3 versus TACE alone in patients with advanced hepatocellular carcinoma. Int J Med Radiol 05(39):119\u2013119","journal-title":"Int J Med Radiol"},{"key":"3941_CR139","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.intimp.2018.03.030","volume":"59","author":"YD Zhou","year":"2018","unstructured":"Zhou YD, Hou JG, Liu W et al (2018) 20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K\/AKT pathway-mediated inflammation and apoptosis. Int Immunopharmacol 59:21\u201330","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3941_CR140","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.apsb.2018.11.004","volume":"9","author":"J Zhou","year":"2019","unstructured":"Zhou J, Huang N, Guo Y et al (2019) Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis. Acta Pharm Sin B 9(3):526\u2013536","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"3941_CR141","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jgr.2022.09.006","volume":"47","author":"Z Zhuang","year":"2023","unstructured":"Zhuang Z, Chen Q, Zhong X et al (2023) Ginsenoside Rg3, a promising agent for NSCLC patients in the pandemic: a large-scale data mining and systemic biological analysis. J Ginseng Res 47(2):291\u2013301","journal-title":"J Ginseng Res"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03941-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03941-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03941-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:28:58Z","timestamp":1738132138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03941-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3941"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03941-w","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}